The Dalai Lama said on Wednesday that after his death he would be reincarnated as the next spiritual leader, and that only the Gaden Phodrang Trust would be able to identify his successor.
Dalai Lama looks on as offerings presented by Buddhist followers are laid on a table during a Long Life Prayer offering ceremony at the Main Tibetan Temple in McLeod Ganj, near Dharamsala, India, on June 30, 2025.(Photo: Getty Images)
Vivek Mishra works as an Assistant Editor with Eastern Eye and has over 13 years of experience in journalism. His areas of interest include politics, international affairs, current events, and sports. With a background in newsroom operations and editorial planning, he has reported and edited stories on major national and global developments.
A SENIOR Indian minister has said that only the Dalai Lama and the organisation he has established have the authority to decide his successor as the spiritual leader of Tibetan Buddhism. The comment runs contrary to China’s long-standing position on the matter.
The Dalai Lama, who fled to India in 1959 following a failed uprising against Chinese rule, said on Wednesday that after his death he would be reincarnated as the next spiritual leader, and that only the Gaden Phodrang Trust would be able to identify his successor. He had earlier said that the next Dalai Lama would be born outside China.
China has maintained that it has the right to approve the next Dalai Lama, citing a legacy from imperial times.
Rijiju: Only Dalai Lama or his institution can decide
India’s minister of parliamentary and minority affairs, Kiren Rijiju, made a rare comment on the issue on Thursday. He was speaking ahead of a planned visit to the Dalai Lama’s base in Dharamshala, where the spiritual leader will celebrate his 90th birthday on Sunday.
“No one has the right to interfere or decide who the successor of His Holiness the Dalai Lama will be,” Indian media quoted Rijiju as saying.
“Only he or his institution has the authority to make that decision. His followers believe that deeply. It’s important for disciples across the world that he decides his succession.”
China warns India over remarks
Following Rijiju’s comments, China’s foreign ministry on Friday warned India against interfering in its internal affairs and urged it to act with caution.
“We hope the Indian side will fully understand the highly sensitive nature of Tibet-related issues, recognise the anti-China separatist nature of the 14th Dalai Lama,” spokesperson Mao Ning said at a regular press conference.
India’s foreign ministry did not respond to a request for comment on the Dalai Lama’s succession plan.
Rijiju, who is a practising Buddhist, is expected to be joined by other Indian officials for the birthday celebrations in Dharamshala.
India is home to tens of thousands of Tibetan Buddhists, who are allowed to live, study and work freely. The Dalai Lama remains a respected figure in India, and foreign policy analysts say his presence gives India some diplomatic leverage in its relations with China.
Ties between the two countries deteriorated sharply after a deadly border clash in 2020 but are now slowly improving.
A nurse walks through an alley at the Government Medical College, where children were admitted after consuming Coldrif cough syrup, which has been linked to the deaths of multiple children, in Nagpur, India, October 8, 2025.
INDIAN police have arrested the owner of a pharmaceutical company after a cough syrup made at his plant was linked to the deaths of at least 21 children, officials said on Thursday.
Most of the children, all under the age of five, died in Madhya Pradesh over the past month after being prescribed the syrup, which was found to be contaminated with a toxic substance.
Cough syrups manufactured in India have come under global scrutiny in recent years following deaths in several countries linked to their consumption. The incidents have affected India’s reputation as the world’s third-largest producer of drugs and pharmaceuticals by volume.
G. Ranganathan, 75, was arrested early on Thursday at his home in Chennai by police teams from Chennai and Madhya Pradesh.
He was charged with culpable homicide not amounting to murder and adulteration of drugs, police sources told AFP and Indian media reported.
The syrup, sold under the brand name Coldrif, was manufactured by Sresan Pharma at a unit in Tamil Nadu.
The Indian health ministry said on Saturday that tests on samples showed contamination with diethylene glycol (DEG), a toxic chemical used in industrial solvents that can be fatal even in small quantities.
Authorities in Madhya Pradesh and several other states have banned the product.
Indian media reported that the World Health Organization had asked Indian officials for clarification on whether the contaminated syrup had been exported to other countries.
In 2022, more than 70 children died in Gambia from acute kidney failure after consuming a cough syrup imported from India.
Between 2022 and 2023, 68 children in Uzbekistan died after consuming another contaminated syrup made in India.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.